The company also issued a 2025 guidance that fell short of expectations, as some of the company’s older drugs face ...

Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...

Pfizer CEO Albert Bourla told investors he dined with RFK Jr, a vaccine skeptic and nominee to head HHS. They discussed ...

Pfizer reported strong 2024 profits Wednesday on the same day the Connecticut Attorney General’s office released a statement ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...

The deal was signed with the Energize programme, a renewable energy purchasing vehicle for pharmeceutical companies.

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

Shares of vaccine companies such as Moderna (MRNA), Pfizer (PFE) and BioNTech (BNTX), among others, are falling after a ...

Pfizer shares are moving higher on Wednesday as the sector sees volatility amid Robert F. Kennedy Jr.'s nomination as the secretary of the Department of Health and Human Services.

BMS acquired Cobenfy as part of its $14 billion takeover of Karuna Therapeutics towards the end of 2023, and analysts at ...